Receive The Newest Study Notifications

Adial Pharmaceuticals Receives Approval to Commence Phase 3 Trial in Bulgaria

by Lance Smith | Feb 20, 2020 | Study Scavenger Clinical Trial Recruitment Platform

CHARLOTTESVILLE, VA / ACCESSWIRE / February 19, 2020 / Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for addiction, today announced that it has received approval to commence its...

VBL Therapeutics Announces the Launch of a New Clinical Trial of VB-111 Combined with the Checkpoint Inhibitor, Nivolumab, in Metastatic Colorectal Cancer

by Lance Smith | Feb 20, 2020 | Study Scavenger Clinical Trial Recruitment Platform

This clinical trial will investigate for the first time a combination of VB-111 with a checkpoint inhibitor. Pathology readouts are expected to shed light on the potential of VB-111 to turn “cold” colorectal tumors “hot.” TEL AVIV, Israel, Feb. 20, 2020 (GLOBE...

Worldwide Clinical Trials Expands Executive Team with Key New Hire, Mike Mencer as EVP and General Manager, Early Phase Services

by Lance Smith | Feb 20, 2020 | Study Scavenger Clinical Trial Recruitment Platform

Worldwide Clinical Trials, Inc. (Worldwide), an award-winning, full-service, midsize, global contract research organization (CRO), announced today that Mike Mencer has joined the company as the EVP and General Manager of Worldwide’s Early Phase Services, focusing on...

The Cardiac & Vascular Institute First in Florida to Enroll Patients in New Clinical Trial Studying LimFlow Therapy

by Lance Smith | Feb 20, 2020 | Study Scavenger Clinical Trial Recruitment Platform

Gainesville, FL, February 20, 2020 –(PR.com)– The Cardiac & Vascular Institute (TCAVI) announced it is the first in Florida to perform a successful procedure in the PROMISE II pivotal study of the LimFlow Percutaneous Deep Vein Arterialization System...

Axsome Therapeutics Completes Patient Enrollment in the INTERCEPT Phase 3 Trial of AXS-07 in the Early Treatment of Migraine

by Lance Smith | Feb 20, 2020 | Study Scavenger Clinical Trial Recruitment Platform

NEW YORK, Feb. 20, 2020 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced the completion of patient...

Teva Announces Registration Trials of Deutetrabenazine in Pediatric Patients with Tourette Syndrome Did Not Meet the Primary Endpoint

by Lance Smith | Feb 20, 2020 | Study Scavenger Clinical Trial Recruitment Platform

TEL AVIV, Israel–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the Phase 2/3 ARTISTS 1 and Phase 3 ARTISTS 2 trials designed to evaluate deutetrabenazine compared to placebo for the treatment of tics in pediatric...